Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Paul Gurbel and Kevin Bliden.
Paul Gurbel
Connection Strength
1.687
Kevin Bliden
  1. Thrombogenicity markers for early diagnosis and prognosis in COVID-19: a change from the current paradigm? Blood Coagul Fibrinolysis. 2021 Dec 01; 32(8):544-549.
    View in: PubMed
    Score: 0.245
  2. The role of viscoelastic testing in assessing peri-interventional platelet function and coagulation. Platelets. 2021 Aug 09; 1-11.
    View in: PubMed
    Score: 0.240
  3. First Experience Addressing the Prognostic Utility of Novel Urinary Biomarkers in Patients With COVID-19. Open Forum Infect Dis. 2021 Jul; 8(7):ofab274.
    View in: PubMed
    Score: 0.237
  4. Bedside thromboelastography to rapidly assess the pharmacodynamic response of anticoagulants and aspirin in COVID-19: evidence of inadequate therapy in a predominantly minority population. J Thromb Thrombolysis. 2021 May; 51(4):902-904.
    View in: PubMed
    Score: 0.235
  5. Race-Related disparities in COVID-19 thrombotic outcomes: Beyond social and economic explanations. EClinicalMedicine. 2020 Dec; 29:100647.
    View in: PubMed
    Score: 0.229
  6. Personalizing Antithrombotic Therapy in COVID-19: Role of Thromboelastography and Thromboelastometry. Thromb Haemost. 2020 11; 120(11):1594-1596.
    View in: PubMed
    Score: 0.223
  7. Can an Old Ally Defeat a New Enemy? Circulation. 2020 07 28; 142(4):315-317.
    View in: PubMed
    Score: 0.221
  8. Quantification of antibody avidities and accurate detection of SARS-CoV-2 antibodies in serum and saliva on plasmonic substrates. Nat Biomed Eng. 2020 12; 4(12):1188-1196.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.